Professor Laura van ‘t Veer (IMAGE)

European Organisation for Research and Treatment of Cancer

Professor Laura van ‘t Veer

Caption

Professor Laura van ‘t Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conference in Milan. Researchers have developed a genetic test that identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies.

Credit

Credit Professor Laura van ‘t Veer

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.